Annick Mühlethaler‐Mottet

3.7k total citations · 1 hit paper
38 papers, 3.0k citations indexed

About

Annick Mühlethaler‐Mottet is a scholar working on Neurology, Immunology and Molecular Biology. According to data from OpenAlex, Annick Mühlethaler‐Mottet has authored 38 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 16 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Annick Mühlethaler‐Mottet's work include Neuroblastoma Research and Treatments (22 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (10 papers). Annick Mühlethaler‐Mottet is often cited by papers focused on Neuroblastoma Research and Treatments (22 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (10 papers). Annick Mühlethaler‐Mottet collaborates with scholars based in Switzerland, France and United States. Annick Mühlethaler‐Mottet's co-authors include Bernard Mach, Viktor Steimle, Claire-Anne Siegrist, Barbara Lisowska‐Grospierre, Walter Reith, Krzysztof Masternak, L. Otten, Nicole Groß, Jean Villard and Jean‐Marc Joseph and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Annick Mühlethaler‐Mottet

37 papers receiving 3.0k citations

Hit Papers

Regulation of MHC Class II Expression by Interferon-γ Med... 1994 2026 2004 2015 1994 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
    1994 714 citations Viktor Steimle, Annick Mühlethaler‐Mottet et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annick Mühlethaler‐Mottet Switzerland 24 1.9k 1.1k 822 333 327 38 3.0k
George Blanck United States 23 1.5k 0.8× 1.0k 1.0× 1.1k 1.3× 287 0.9× 104 0.3× 157 2.7k
Carmela De Santo United Kingdom 25 2.6k 1.4× 752 0.7× 1.3k 1.5× 351 1.1× 87 0.3× 40 3.6k
Nathalie Bendriss‐Vermare France 35 3.4k 1.8× 842 0.8× 2.0k 2.4× 274 0.8× 83 0.3× 63 4.5k
Frank Grünebach Germany 38 2.4k 1.3× 1.8k 1.7× 1.3k 1.5× 376 1.1× 92 0.3× 73 4.2k
Andreas Gewies Germany 18 1.1k 0.6× 785 0.7× 352 0.4× 513 1.5× 236 0.7× 31 2.3k
Jonathan S. Maltzman United States 25 1.8k 1.0× 765 0.7× 789 1.0× 137 0.4× 75 0.2× 60 3.0k
Shingo Ichimiya Japan 29 797 0.4× 857 0.8× 594 0.7× 197 0.6× 79 0.2× 100 2.3k
Teruhito Yasui Japan 26 1.4k 0.7× 645 0.6× 857 1.0× 299 0.9× 61 0.2× 47 2.6k
Mikyoung Chang United States 21 1.6k 0.8× 1.2k 1.1× 514 0.6× 843 2.5× 53 0.2× 24 2.6k
Annaiah Cariappa United States 24 2.4k 1.3× 958 0.9× 344 0.4× 360 1.1× 51 0.2× 34 3.3k

Countries citing papers authored by Annick Mühlethaler‐Mottet

Since Specialization
Citations

This map shows the geographic impact of Annick Mühlethaler‐Mottet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick Mühlethaler‐Mottet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick Mühlethaler‐Mottet more than expected).

Fields of papers citing papers by Annick Mühlethaler‐Mottet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annick Mühlethaler‐Mottet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick Mühlethaler‐Mottet. The network helps show where Annick Mühlethaler‐Mottet may publish in the future.

Co-authorship network of co-authors of Annick Mühlethaler‐Mottet

This figure shows the co-authorship network connecting the top 25 collaborators of Annick Mühlethaler‐Mottet. A scholar is included among the top collaborators of Annick Mühlethaler‐Mottet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annick Mühlethaler‐Mottet. Annick Mühlethaler‐Mottet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colombo, Daniele, Rajendran Sanalkumar, Liliane C. Broye, et al.. (2024). Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma. JCI Insight. 9(14).
2.
Mühlethaler‐Mottet, Annick, Silvia Uccella, Stefano La Rosa, et al.. (2022). Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension. Frontiers in Endocrinology. 13. 1027856–1027856. 2 indexed citations
3.
Praz, Viviane, Katia Balmas Bourloud, Jean‐Marc Joseph, et al.. (2022). TWIST1 expression is associated with high-risk neuroblastoma and promotes primary and metastatic tumor growth. Communications Biology. 5(1). 42–42. 7 indexed citations
4.
Mühlethaler‐Mottet, Annick, Kelly Ascenção, Marjorie Flahaut, et al.. (2015). The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing. PLoS ONE. 10(5). e0125616–e0125616. 23 indexed citations
5.
Sartelet, Hervé, Marjorie Flahaut, Annick Mühlethaler‐Mottet, et al.. (2012). Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma. PLoS ONE. 7(8). e43665–e43665. 58 indexed citations
6.
Mühlethaler‐Mottet, Annick, Marjorie Flahaut, Katia Balmas Bourloud, et al.. (2011). Individual caspase-10 isoforms play distinct and opposing roles in the initiation of death receptor-mediated tumour cell apoptosis. Cell Death and Disease. 2(3). e125–e125. 23 indexed citations
7.
Coulon, Aurélie, Marjorie Flahaut, Annick Mühlethaler‐Mottet, et al.. (2011). Functional Sphere Profiling Reveals the Complexity of Neuroblastoma Tumor-Initiating Cell Model. Neoplasia. 13(10). 991–IN30. 57 indexed citations
8.
Raguénez, Gilda, et al.. (2009). Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma. BMC Cancer. 9(1). 97–97. 13 indexed citations
9.
Flahaut, Marjorie, Roland Meier, Aurélie Coulon, et al.. (2009). The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway. Oncogene. 28(23). 2245–2256. 153 indexed citations
10.
Mühlethaler‐Mottet, Annick, Roland Meier, Marjorie Flahaut, et al.. (2008). Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells. Molecular Cancer. 7(1). 55–55. 55 indexed citations
11.
Flahaut, Marjorie, Annick Mühlethaler‐Mottet, Danielle Martinet, et al.. (2006). Molecular cytogenetic characterization of doxorubicin‐resistant neuroblastoma cell lines: Evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region. Genes Chromosomes and Cancer. 45(5). 495–508. 19 indexed citations
12.
Mühlethaler‐Mottet, Annick, Marjorie Flahaut, Katia Balmas Bourloud, et al.. (2006). Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio. BMC Cancer. 6(1). 214–214. 39 indexed citations
13.
Mühlethaler‐Mottet, Annick, Michał Krawczyk, Krzysztof Masternak, et al.. (2004). The S Box of Major Histocompatibility Complex Class II Promoters Is a Key Determinant for Recruitment of the Transcriptional Co-activator CIITA. Journal of Biological Chemistry. 279(39). 40529–40535. 23 indexed citations
14.
15.
Hopkins-Donaldson, Sally, Pu Yan, Katia Balmas Bourloud, et al.. (2002). Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells. Oncogene. 21(39). 6132–6137. 41 indexed citations
16.
Janitz, Michael, et al.. (2001). Analysis of the Sequence Polymorphism within Class II Transactivator Gene Promoters. PubMed. 18(4). 199–205. 8 indexed citations
17.
Suter, Tobias, Ursula Malipiero, L. Otten, et al.. (2000). Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis. European Journal of Immunology. 30(3). 794–802. 2 indexed citations
18.
Masternak, Krzysztof, Annick Mühlethaler‐Mottet, Jean Villard, et al.. (2000). CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes & Development. 14(9). 1156–1166. 292 indexed citations
19.
Villard, Jean, Annick Mühlethaler‐Mottet, Séverine Bontron, Bernard Mach, & Walter Reith. (1999). CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes. International Immunology. 11(3). 461–469. 23 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Blanck Breakdown of academic impact, for papers by Carmela De Santo Breakdown of academic impact, for papers by Nathalie Bendriss‐Vermare Breakdown of academic impact, for papers by Frank Grünebach Breakdown of academic impact, for papers by Andreas Gewies Breakdown of academic impact, for papers by Jonathan S. Maltzman Breakdown of academic impact, for papers by Shingo Ichimiya Breakdown of academic impact, for papers by Teruhito Yasui Breakdown of academic impact, for papers by Mikyoung Chang Breakdown of academic impact, for papers by Annaiah Cariappa
Rankless by CCL
2026